SHOP APOTHEKE EUROPE N.V.

  • WKN: A2AR94
  • ISIN: NL0012044747
  • Land: Niederlande

Nachricht vom 14.06.2019 | 17:57

Groundbreaking for new logistics centre: SHOP APOTHEKE EUROPE presents the online pharmacy of the future.

DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Miscellaneous/Real Estate

14.06.2019 / 17:57
The issuer is solely responsible for the content of this announcement.


Groundbreaking for new logistics centre.

SHOP APOTHEKE EUROPE presents the online pharmacy of the future.

Venlo, the Netherlands, June 14, 2019. With the start of construction for its new corporate headquarters, SHOP APOTHEKE EUROPE passes another milestone in the success story of one of the leading online pharmacies in Continental Europe. The operating area will double to 40,000 square meters at the new building in Sevenum near Venlo in the Netherlands. The site's core will be a state-of-the-art logistics hub that is designed to keep pace with SHOP APOTHEKE EUROPE's steadily growing order volume and to speed up all processes involved in the shipment of over-the-counter and prescription medications and beauty products.

SHOP APOTHEKE EUROPE and its construction company Somerset Capital Partners have invited political leaders from the Dutch-German border region as well as staff members and neighbouring businesses to the construction site for the groundbreaking ceremony. The economic officer of Provincie Limburg, Dr. Joost van den Akker sees in the construction project demonstrates the growth potential of a strong economic area with optimal transport links. "The arrival of the new distribution centre fits in perfectly with the ambitions of the province of Limburg to increase and maintain employment and to further expand international trade in the area by means of logistic connections."

Most of the approximately 850 employees of SHOP APOTHEKE EUROPE live in the nearby cities and towns on the German side of the border. 175 employees work in Cologne from where they steer the company's e-commerce and other business activities.

Host Stefan Feltens, CEO of SHOP APOTHEKE EUROPE, used the groundbreaking ceremony to provide a glance into the future of the rapidly expanding online pharmacy: "Our goal is to continue to grow faster than our competitors and serving our markets from Venlo" he stated. In a few years, the new logistics centre could increase the shipping volume from 8.5 million parcels a year to 35 million parcels a year. The forecast of the online pharmacy's continued rapid growth is also based on the planned introduction of electronic prescriptions. As a full-service pharmacy, SHOP APOTHEKE EUROPE supplies customers in Germany exclusively with German prescription medications. Chief Pharmacist and COO Theresa Holler promised an even greater choice of products and an even faster supply with medicines to SHOP APOTHEKE EUROPE'S customers: "The ordering and delivery processes will get easier and the individual counseling services for patients continue to be in the focus," she summarized.

In connection with the local relocation of the company's headquarters planned for autumn 2020 and will last for several months, SHOP APOTHEKE EUROPE is further intensifying the search for new employees. Currently, new colleagues are being sought for the customer service, finance, pharma, logistics and IT areas.

You can find more information, images and video podcasts on SHOP APOTHEKE EUROPE's new headquarters at https://shop-apotheke-europe.com/en/press/downloads.
 

ABOUT SHOP APOTHEKE EUROPE.

SHOP APOTHEKE EUROPE is one of the leading and fastest-growing online pharmacies in Continental Europe. With the acquisition of Europa Apotheek Venlo in November 2017, SHOP APOTHEKE EUROPE significantly extended its European market leadership. The product range for the whole family in the OTC, beauty and personal care products as well as prescription drugs segments is supplemented by high quality natural food and health products, low carb products and sports nutrition following the acquisition of nu3 GmbH in July 2018.

SHOP APOTHEKE EUROPE already operates online pharmacies in Germany, Austria, France, Belgium, Italy, Spain, the Netherlands and Switzerland.

SHOP APOTHEKE EUROPE delivers a broad range of more than 100,000 original products to over 3.8 million active customers fast and at attractive prices. In addition, SHOP APOTHEKE EUROPE provides comprehensive pharmaceutical consulting services.

SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 13 October 2016 and is part of the SDAX index since 24 September 2018.

MEDIA CONTACTS.

Trade and popular media:
Sven Schirmer
Phone: +49 221 99 53 44 31
Email: presse@shop-apotheke.com

Financial media:
Thomas Schnorrenberg
Mobile: +49 151 46 53 13 17
Email: presse@shop-apotheke.com

Investor relations:
Dr. Ulrich Wandel
Phone: +31 77 850 6117
Email: ulrich.wandel@shop-apotheke.com



14.06.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Anleihe im Fokus

„Semper idem Underberg AG: Emission neuer Unternehmensanleihe 2019/2025“

- Emissionsvolumen: bis zu 60 Mio. Euro
- Anleihenumtausch: 23.010. bis 06.11.2019
- Neuzeichnung: 07.11. bis 12.11.2019
- ISIN: DE000A2YPAJ3 / WKN: A2YPAJ
- Stückelung / Mindestanlage: 1.000 Euro
- Zinssatz (Kupon):
Liegt in einer Spanne von 4,00 % bis 4,25 % p.a.
- Laufzeit: 6 Jahre
- Zinszahlung: jährlich, jeweils am 18. November (nachträglich), erstmals am 18. November 2020
- Rückzahlungskurs: 100%
- Fälligkeit: 18. November 2025
- Listing: Listing im Freiverkehr (Open Market) der Frankfurter Wertpapierbörse vorgesehen

GBC-Fokusbox

Expedeon AG mit attraktiver Produktpipeline

Durch die konsequente Fortsetzung der „Grow, Buy & Build“-Strategie hat die im Bereich der Entwicklung und Vermarktung von DNA-Technologien, Proteomik- und Antikörper-Konjugations-Anwendungen tätige Expedeon AG das Umsatzniveau angehoben und auf operativer Ergebnisebene zugleich den Break-Even nachhaltig überschritten. Für die kommenden Perioden ist der Ausbau der Umsatzerlöse mit den bestehenden Produkten geplant. Darüber hinaus verfügt die Expedeon AG über eine attraktive Produktpipeline mit hohem Umsatzpotenzial. Unser Kursziel liegt bei 3,20 € je Aktie. Das Rating lautet KAUFEN.

News im Fokus

Continental AG: Continental AG berücksichtigt im dritten Quartal 2019 nicht zahlungswirksame Wertminderungen und Restrukturierungsrückstellungen

22. Oktober 2019, 13:34

Aktuelle Research-Studie

CO.DON AG

Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy

21. Oktober 2019